| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |